Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor

  • Authors:
    • Ian S. Zagon
    • Shawn Kreiner
    • Jeffery J. Heslop
    • Andrea B. Conway
    • Clinton R. Morgan
    • Patricia J. McLaughlin
  • View Affiliations

  • Published online on: August 1, 2008     https://doi.org/10.3892/ijo_00000011
  • Pages: 317-323
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study examined overexpression of the opioid growth factor receptor (OGFr) in pancreatic cancer cells and phenotypic changes in tumorigenicity. Tumors of MIA PaCa-2 cells transfected with OGFr cDNA (OGFr-1) had 3.3 times more OGFr than empty vector (EV) neoplasias, and 4.3 times more OGFr than tumors from wild-type (WT) mice. No differences in OGFr binding were detected between tumors of EV and WT animals. Tumor incidence in OGFr-1 animals was reduced by up to 50% from EV mice. Latency times for OGFr-1 tumor expression were increased 30%, tumor volume was decreased 70%, and DNA synthesis was reduced 24% relative to EV mice. Exogenous OGF reduced OGFr-1 tumor volume up to 55% compared to OGFr-1 mice given vehicle. These data support OGFr gene function as a regulator of cell proliferation that impacts on tumorigenic expression, and suggest that molecular and pharmacological manipulation of OGFr may prevent or delay human pancreatic cancer.

Related Articles

Journal Cover

August 2008
Volume 33 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zagon IS, Kreiner S, Heslop JJ, Conway AB, Morgan CR and McLaughlin PJ: Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor. Int J Oncol 33: 317-323, 2008
APA
Zagon, I.S., Kreiner, S., Heslop, J.J., Conway, A.B., Morgan, C.R., & McLaughlin, P.J. (2008). Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor. International Journal of Oncology, 33, 317-323. https://doi.org/10.3892/ijo_00000011
MLA
Zagon, I. S., Kreiner, S., Heslop, J. J., Conway, A. B., Morgan, C. R., McLaughlin, P. J."Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor". International Journal of Oncology 33.2 (2008): 317-323.
Chicago
Zagon, I. S., Kreiner, S., Heslop, J. J., Conway, A. B., Morgan, C. R., McLaughlin, P. J."Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor". International Journal of Oncology 33, no. 2 (2008): 317-323. https://doi.org/10.3892/ijo_00000011